Access 2.8M+ Filings Sign Up Free
M WINKWORTH PLC Logo

M WINKWORTH PLC | WINK - Profile, Filings, Stock Info & Investor Relations Data

M WINKWORTH PLC | WINK
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Industry
Biotechnology
Country
United Kingdom
Founded
N/A
M WINKWORTH PLC (WINK)

Company Profile

About M WINKWORTH PLC

N4 Pharma PLC develops and licenses Nuvec¨, a novel silica nanoparticle drug delivery system enhancing vaccines & therapeutics. Established 2014, the company focuses on improving nucleic acid delivery for gene therapy, cancer treatment, and vaccines.

Headquarters

13 CHARLES II STREET, ST. JAMES'S
SW1Y 4QU, LONDON
United Kingdom

M WINKWORTH PLC (WINK)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Get Notified About M WINKWORTH PLC's New Filings

Receive email alerts when new documents are published.

You can unsubscribe at any time.

M WINKWORTH PLC (WINK)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

No Insider Trades

There is currently no insider trading data available for this company.

M WINKWORTH PLC (WINK)
Stock & Investor Information

ISINs

GB00B4TT7L53

LEI

213800W7G6NJ2PRNUM27

Stock Exchange Listings

London Stock Exchange

Stock Index Memberships

AIM (LSE)

Industry Classification

Sector
Health Care
Industry
Biotechnology